Two methods of prostate cancer biopsy demonstrated similar, minimal rates of infection in patients with prostate cancer, according to a recent Northwestern Medicine study published in the journal European Urology.
Fourth-year Feinberg students excitedly tore open envelopes to reveal their residency matches at this year’s Match Day celebration on March 15.
High school juniors from Our Lady of Tepeyac High School in Little Village had the chance to shadow and learn from Feinberg scientists as part of an event hosted by the Simpson Querrey Institute for Epigenetics’ (SQE) Inspire program on March 5.
A recent Northwestern Medicine study sheds light on the mechanisms of a specific protein that is necessary for the production of IgA antibodies in the gut in response to food allergens, according to findings published in the journal Mucosal Immunology.
Northwestern Medicine scientists have identified new genes implicated in the development of uterine fibroids, according to a study published in Nature Communications.
As GLP-1 receptor agonist medications like semaglutide have been shown to be effective at helping patients lose weight, scientists are now asking, whether they can treat other conditions where obesity is a risk factor. Most recently, initial studies have shown that they can reduce the risk of cardiovascular disease by reducing overall body weight.
Faculty, residents, trainees and students from Feinberg, the local community and beyond recently came together for Health Equity Week, a week-long series of educational programming designed to expose the roots of healthcare inequities as well as avenues to addressing them.
Women in the healthcare field and their allies convened in the Feinberg Pavilion at Northwestern Memorial Hospital to celebrate women’s empowerment and success during the sixth annual Women in Medicine Conference on March 8.
A mutated protein expressed in lysosomes may contribute to Parkinson’s disease, according to a new Northwestern Medicine study published in the Journal of Cell Biology.
Thrombolytic therapy administered longer after the onset of ischemic stroke than current recommendations did not demonstrate improved clinical outcomes as compared to placebo, according to a recent trial published in the New England Journal of Medicine.